Ophthalmology
We undertake high quality clinical and translational research in order to improve the treatment of preventable blindness, carrying out both research and teaching in the University and provides a clinical ophthalmology service.
Trauma, inflammation and infection at the ocular surface causes damage, which without effective treatment, accounts for up to 2 million new cases of monocular blindness every year, adding to the existing 39 million cases worldwide.
In addition, age-related macular degeneration and diabetic retinopathy are the most common causes of preventable blindness in the western world, AMD in the ageing population and diabetic retinopathy in the working population. This has significant physical and psychological impact on the patient as well as having profound consequences for their families and socio-economic impact on the community.
The high financial cost of avoidable visual loss makes it an important public health concern. Unfortunately, current treatment strategies for these patients are subject to many limitations, therefore creating a great need for research in this area.
Our research